Hot Life Science Investor Mandate 2: Venture Capital Firm Seeking Therapeutics for Blood Diseases

6 Feb

A venture capital firm based in the Western United States recently raised a $50M fund with a specific focus in blood-related therapeutics and technologies. The firm can allocate up to $10M per company depending on the financial needs of the company. The firm will consider companies located worldwide. The firm is actively seeking new investment opportunities.

The firm is currently looking to invest in regenerative medicine with particular interest in therapeutics for blood diseases and blood-related technologies/products. The firm is particularly interested in cord blood stem cells and the regeneration of red blood cells. The firm will invest in products in early clinical (Phase I) through Phase III of clinical trials. 

The firm seeks companies with an experienced management teams or technical experts in the relevant technology.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: